MedTrace Logo

Effect of a Village Doctor-delivered Exercise Therapy for Knee Osteoarthritis

NCT07638020 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2026-06-10

No results posted yet for this study

Summary

The goal of this clinical trial is to test the feasibility of village doctor-delivered exercise therapy for knee osteoarthritis in rural China, and to preliminarily explore its treatment effects. The main questions it aims to answer are:

1. Is the exercise therapy delivered by village doctors feasible with satisfactory participant adherence?
2. Can this intervention produce preliminary benefits in this small pilot sample? Researchers will compare village doctor-delivered exercise therapy to usual care to see if the intervention leads to greater pain relief and functional improvement in this pilot study.

Participants will complete village-delivered exercise therapy three times a week for 12 weeks, then maintain independent exercise for another 12 weeks or receive usual care for a total of 24 weeks.

Conditions

Interventions

BEHAVIORAL

Exercise

The village doctor-delivered exercise program will be conducted over 12 weeks, with participants engaging in three sessions per week, each lasting approximately 50 minutes. To prevent excessive fatigue, each session will be scheduled with at least a one-day interval. Each session will consist of three phases: a warm-up phase, an exercise phase, and a cool-down phase. Following the 12-week exercise program supervised by village doctors, participants in the intervention group will be encouraged by researchers and village doctors to continue the exercise program without supervision until the 24-week follow-up.

BEHAVIORAL

Usual Care

Participants will seek medical attention and address their knee pain issues according to their past habits, but should not increase the use of previously unused treatment methods or adopt invasive treatment methods during the study period.

Sponsors & Collaborators

  • Xiangya Hospital of Central South University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-03
Primary Completion
2025-09-28
Completion
2025-12-20

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07638020 on ClinicalTrials.gov